122 related articles for article (PubMed ID: 23000598)
1. Development of robust hepatitis C virus genotype 4 subgenomic replicons.
Peng B; Yu M; Xu S; Lee YJ; Tian Y; Yang H; Chan K; Mo H; McHutchison J; Delaney W; Cheng G
Gastroenterology; 2013 Jan; 144(1):59-61.e6. PubMed ID: 23000598
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
[TBL] [Abstract][Full Text] [Related]
3. Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a.
Robinson M; Yang H; Sun SC; Peng B; Tian Y; Pagratis N; Greenstein AE; Delaney WE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3099-106. PubMed ID: 20516274
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
Wose Kinge CN; Espiritu C; Prabdial-Sing N; Sithebe NP; Saeed M; Rice CM
Antimicrob Agents Chemother; 2014 Sep; 58(9):5386-94. PubMed ID: 24982066
[TBL] [Abstract][Full Text] [Related]
5. Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.
Yu M; Peng B; Chan K; Gong R; Yang H; Delaney W; Cheng G
Antimicrob Agents Chemother; 2014 May; 58(5):2638-46. PubMed ID: 24550344
[TBL] [Abstract][Full Text] [Related]
6. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
[TBL] [Abstract][Full Text] [Related]
8. Replication of hepatitis C virus genotype 3a in cultured cells.
Saeed M; Gondeau C; Hmwe S; Yokokawa H; Date T; Suzuki T; Kato T; Maurel P; Wakita T
Gastroenterology; 2013 Jan; 144(1):56-58.e7. PubMed ID: 22999961
[TBL] [Abstract][Full Text] [Related]
9. Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
Saeed M; Scheel TK; Gottwein JM; Marukian S; Dustin LB; Bukh J; Rice CM
Antimicrob Agents Chemother; 2012 Oct; 56(10):5365-73. PubMed ID: 22869572
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.
Howe AY; Cheng H; Johann S; Mullen S; Chunduru SK; Young DC; Bard J; Chopra R; Krishnamurthy G; Mansour T; O'Connell J
Antimicrob Agents Chemother; 2008 Sep; 52(9):3327-38. PubMed ID: 18559648
[TBL] [Abstract][Full Text] [Related]
12. Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
Camus G; Xu S; Han B; Lu J; Dvory-Sobol H; Yu M; Cheng G; Miller MD; Doehle BP; Mo H
Virology; 2018 Jan; 514():134-141. PubMed ID: 29175627
[TBL] [Abstract][Full Text] [Related]
13. Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells.
Liang C; Rieder E; Hahm B; Jang SK; Paul A; Wimmer E
Virology; 2005 Mar; 333(1):41-53. PubMed ID: 15708591
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain.
Lanford RE; Guerra B; Lee H
Virology; 2006 Nov; 355(2):192-202. PubMed ID: 16919701
[TBL] [Abstract][Full Text] [Related]
15. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
[TBL] [Abstract][Full Text] [Related]
16. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.
Herlihy KJ; Graham JP; Kumpf R; Patick AK; Duggal R; Shi ST
Antimicrob Agents Chemother; 2008 Oct; 52(10):3523-31. PubMed ID: 18694956
[TBL] [Abstract][Full Text] [Related]
17. Comparison of daclatasvir resistance barriers on NS5A from hepatitis C virus genotypes 1 to 6: implications for cross-genotype activity.
Wang C; Jia L; O'Boyle DR; Sun JH; Rigat K; Valera L; Nower P; Huang X; Kienzle B; Roberts S; Gao M; Fridell RA
Antimicrob Agents Chemother; 2014 Sep; 58(9):5155-63. PubMed ID: 24936600
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the Replication of Hepatitis C Virus Replicons of Genotypes 1 to 4 by Manipulation of CpG and UpA Dinucleotide Frequencies and Use of Cell Lines Expressing SECL14L2 for Antiviral Resistance Testing.
Witteveldt J; Martin-Gans M; Simmonds P
Antimicrob Agents Chemother; 2016 May; 60(5):2981-92. PubMed ID: 26953209
[TBL] [Abstract][Full Text] [Related]
19. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
[TBL] [Abstract][Full Text] [Related]
20. Screening of hepatitis C virus inhibitors using genotype 1a HCV replicon cell lines.
Robinson M; Tian Y; Pagratis N; Delaney WE
Curr Protoc Microbiol; 2011 Aug; Chapter 17():Unit17.7. PubMed ID: 21805689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
